Amicus Therapeutics Inc. (FOLD): Palo Alto Investors Sells Half of its Stake At Sky-High Valuation
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD). According to...
Posts Tagged ‘Intermune Inc. (ITMN)’
InterMune Inc (ITMN), United Therapeutics Corporation (UTHR), Cyberonics Inc. (CYBX): Palo Alto Investors Loves Healthcare Stocks
Palo Alto Investors is a hedge fund founded by William Leland Edwards in 1989, and managed by him ever since. The fund invests in small-cap stocks, with...
Orbimed Advisors Cuts Stake In Intercept Pharmaceuticals Inc (ICPT)
Orbimed Advisors is limiting exposure to Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after selling approximately 81,305 shares in one transaction at...
Samuel Isaly Says He Is Fond of Regeneron Pharmaceuticals Inc (REGN) & InterMune Inc (ITMN)
Samuel Isaly‘s Orbimed Advisors is one of the largest hedge funds focused almost entirely on the healthcare sector. In a recent intervention on...
Hedge Funds Are Dumping Dendreon Corporation (DNDN)
What’s a smart Dendreon Corporation (NASDAQ:DNDN) investor to do? To the average investor, there are tons of methods shareholders can use to monitor...
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial...
InterMune Inc (ITMN): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
What’s a smart InterMune Inc (NASDAQ:ITMN) investor to do? To many market players, hedge funds are perceived as delayed, old financial tools of...
Array Biopharma Inc (ARRY), InterMune Inc (ITMN): Three Humongous Health-Care Stocks This Week
After extensive research, number-crunching, sorting, and filtering, the results are in. Here are your three most humongous performers in the world of...
Alexion Pharmaceuticals, Inc. (ALXN), Eli Lilly & Co. (LLY): Five Drugmakers With a Lot on the Line
You may or may not have heard, but it’s earnings season again. Contrary to popular belief, earnings season does actually take a break for a few...
Cytokinetics, Inc. (CYTK), Exelixis, Inc. (EXEL): Three Small Cap Biotech Stocks with Great Potential
Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S. has a number of small cap stocks...
AVEO Pharmaceuticals, Inc. (AVEO), InterMune Inc (ITMN), and Galena Biopharma Inc (GALE): 2 Biotechs To Avoid, 1 To Buy
The earnings season is in full swing and investors are flooded with fundamental information to reassess their investments. While fundamental information...
Hedge Funds Are Buying Workday Inc (WDAY), Post Holdings Inc (POST), and More
Editor’s Note: Related Tickers: Workday Inc (NYSE:WDAY), Post Holdings Inc (NYSE:POST), Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Ultratech,...
5 Stocks Under $10 Worth Buying: Sirius XM Radio Inc (SIRI) and More
If you’ve got ten bucks, I have some stock ideas for you. I’ve been singling out attractive opportunities in low-priced stocks since my original...
Baker Brothers Reports Stakes in InterMune and Repros Therapeutics
Baker Brothers, a healthcare focused hedge fund managed by Julian and Felix Baker, has recently filed with the SEC to disclose significant percentage...
Hedge Fund News: John Paulson, Whitney Tilson, SandRidge Energy Inc. (SD)
Hardly hedging (NYPost) John Paulson, the hedge fund manager who made a fortune during the downturn but more recently blamed a bad 2012 performance on...
Hedge Fund News: Nelson Peltz, Edward Mulé, InterMune Inc.
Ingersoll to Spin Off Unit in Peltz Deal (WSJ) Ingersoll-Rand PLC (NYSE:IR) is expected to announce a plan to spin off its security-technology business...
D. E. Shaw Loses Big After InterMune Drops 18%
InterMune Inc. (ITMN) drops 18.64% at 2:05PM EST today. The stock is trading at $14.88 with unusually high volume on Thursday, down $3.41 from the close...
Steven Cohen’s SAC Capital Increased Its Position in $ITMN
Steven Cohen’s SAC Capital declared on October 14th that the firm has increased its passive stock position in Intermune Inc. (ITMN) to 3.37 million...
